EX-10.1
from 8-K
1 page
P.O. Box 76, Building 37 1st Avenue, North of Cermak Road, Hines, Il 60141 WWW.FSS.VA.GOV in Reply Refer To: 003b6b 06/01/2020 Conrad Mir, President & CEO CALMARE THERAPEUTICS Incorporated 1375 Kings Hwy, Ste 400 Fairfield, Ct, 06824 -5380 Re: Department of Veterans Affairs - Federal Supply Schedule: Contract Award
12/34/56
EX-10
from 8-K/A
22 pages
Securities Purchase Agreement This Securities Purchase Agreement, Dated as of July 16, 2013 (This “Agreement”), Is Entered Into by and Between Competitive Technologies, Inc., a Delaware Corporation (The “Company”), and Tonaquint, Inc., a Utah Corporation, Its Successors and/or Assigns (“Buyer”). Recitals: A
12/34/56
EX-10
from 8-K
29 pages
Securities Purchase Agreement This Securities Purchase Agreement, Dated as of July 16, 2013 (This “Agreement”), Is Entered Into by and Between Competitive Technologies, Inc., a Delaware Corporation (The “Company”), and Tonaquint, Inc., a Utah Corporation, Its Successors and/or Assigns (“Buyer”). Recitals: A
12/34/56
EX-10
from 10-K
15 pages
Factoring and Security Agreement This Factoring Agreement ("Agreement") Is Made as of September 18, 2012 by and Between Competitive Technologies, Inc. ("Seller") and Lsq Funding Group L.C. ("Purchaser"). 1. Sale; Purchase Price; Billing; Reserve. 1.1. Assignment and Sale. 1.1.1. Seller Shall Offer to Sell to Purchaser as Absolute Owner Such of Seller's Accounts as Are Listed From Time to Time on a Schedule of Accounts. 1.1.2. Each Schedule of Accounts Shall Be Accompanied by Such Documentation Supporting and Evidencing the Account as Purchaser Shall From Time to Time Request. 1.1.3. Purchaser Shall Purchase From Seller Such Accounts as Purchaser Agrees to Purchase in Its Sole Discretion, So Long as the Balance Subject to Funds Usage Fee Does Not Exceed, Before and After Such Purchase, the Maximum Amount. 1.1.4
12/34/56
EX-10
from 8-K
1 page
1) Position Title: President/CEO Competitive Technologies, Inc. 2) Trial Period: Mutually Agreed to Be 60 (Sixty) Days From Starting Date. 3) Base Salary: $ 250,000 Pa, Rising to $ 300,000 Pa Upon Satisfactory Completion of the Trial Period. 4) Bonus: 100% of Base, Subject to Meeting Clearly Defined and Board Approved Goals and Objectives Within Given Time Frames. Payment of the Bonus to Be a Combination of Cash and Equity. 5) Stock Options: You Will Be Granted One Million Incentive Options That Will Be Subject to a New Stock Option Plan That Will Put Into Effect by the Company. Key Elements of the Plan Are That These Options Will Vest Over a Five Year Period and Will Be Subject to a Dribbling Clause. 6) Benefits: You Will Be Enrolled in the Company’s Benefit Program for Medical, Dental and Vision. Details of the Program Will Be Communicated to You Under Separate Cover. 7) Board Position: As CEO, You Will Be a Member of the Board. 8) Start Date: November 1st, 2012
12/34/56
